mergers and acquisitions
Transactions in the pharma sector: Through the EU merger review looking-glass
October 31, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing mergers, mergers and acquisitions, pharma
With mergers and acquisitions back in full swing after a period of drought, Alec Burnside (Partner) and Delphine Strohl (Associate) …
Amgen open to larger M&A deals, says CFO
March 8, 2016Sales and Marketing Amgen, mergers and acquisitions
Amgen’s chief financial officer has indicated that the company is ready to consider doing larger deals to buy other companies, …
Pharma: How to make mergers work
January 29, 2016Sales and Marketing mergers and acquisitions
Pharma is no stranger to bursts of M&A activity.
Shire and Baxalta reach $32 billion merger agreement
January 11, 2016Manufacturing and Production, Sales and Marketing Baxalta, Shire, mergers, mergers and acquisitions
One of the industry’s longest-running M&A sagas has finally reached a conclusion, with Shire and Baxalta announcing a $32 billion …
Perrigo rejects $26 billion hostile Mylan takeover bid
November 13, 2015Medical Communications, Sales and Marketing Mylan, Perrigo, mergers and acquisitions
Perrigo has rejected Mylan’s hostile $26 billion bid after a 60% majority of shareholders were unconvinced by the terms by …
AmerisourceBergen acquires sterile compounder PharMEDium for $2.5bn
October 7, 2015Research and Development, Sales and Marketing AmerisourceBergen, mergers and acquisitions
AmerisourceBergen will now source compounded drugs for its hospital clients by manufacturing them itself after spending more than $2.5 billion …
Cardinal Health completes $1.944bn acquisition of J&J’s Cordis
October 6, 2015Manufacturing and Production, Sales and Marketing Cardinal Health, Cordis, mergers and acquisitions
Cardinal Health has completed the acquisition of Johnson & Johnson’s Cordis business: a global leader in cardiology and endovascular devices, …
Teva acquires Mexico’s Rimsa for $2.3 billion
October 5, 2015Research and Development, Sales and Marketing Mexico, Rimsa, Teva, mergers and acquisitions
Strategic Move Enhances Teva’s Presence in Mexico, the Second Largest Market in Latin America and a Major Emerging Market Brings a Portfolio of …
North 51 acquired by Bionical
October 5, 2015Bionical, North 51, mergers and acquisitions
North 51 Ltd, a Nottingham-based healthcare company has been acquired by Bionical in a multi-million pound deal. The North 51 …
Actelion confirms takeover talks with ZS Pharma
September 11, 2015Research and Development, Sales and Marketing Actelion, Shire, ZS Pharma, mergers and acquisitions
Swiss drugmaker Actelion has entered discussions with US biotech company ZS Pharma, over a takeover thought to be worth $2.5 …
Pfizer completes $15 billion Hospira acquisition
September 4, 2015Biosimilar Drugs, Hospira, Pfizer, mergers and acquisitions
Pfizer has completed its acquisition of Illinois-based injectable drugs and infusion device specialist Hospira for around $15 billion.The deal, first announced …
Novo Nordisk to buy two pharma research companies
August 27, 2015Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, mergers and acquisitions
Novo Nordisk is to acquire two privately-held biopharmaceutical research companies specialising in diabetes, for undisclosed sums. Calibrium and MB2, formed …
Abbott to table $25bn bid for medical device maker St Jude?
August 27, 2015Manufacturing and Production, Sales and Marketing Abbott Laboratories, mergers and acquisitions, st jude medical
Abbott Laboratories is said to be preparing a $25 billion takeover bid for medical device maker St Jude Medical. Illinois-based Abbott …
Depomed rejects Horizon’s latest takeover bid
July 30, 2015Sales and Marketing Depomed, horizon, mergers and acquisitions, takeovers
Depomed has rejected Horizon Pharma’s latest bid, stating the proposal is ‘inadequate’ and ’undervalues’ the company. The Irish pharma company …
Teva to switch generics focus to Allergan
July 27, 2015Sales and Marketing Allergan, Teva, generics, mergers and acquisitions, pharma mergers and acquisitions
Teva is in negotiations to buy Allergan’s generics division for upwards of $40 billion, according to reports. The generics firm …
